triptorelin   Click here for help

GtoPdb Ligand ID: 1177

Synonyms: CL 118532 | CL-118532 | Decapeptyl® | Pamorelin® | Trelstar® | Triptodur®
Approved drug
triptorelin is an approved drug (FDA (2001))
Comment: As is the case with many peptide molecules, there is some ambiguity as to the stereochemistry of triptorelin, therefore the chemical structure shown here may vary slightly from that displayed on the resources linked to from the table above. The marketed formulations contain triptorelin pamoate (PubChem CID 25074469) or triptorelin acetate (PubChem CID 25080282).
Click here for help
2D Structure
Click here for help
Click here for structure editor
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1CCCC1C(=O)NCC(=O)N)CCCNC(=N)N)CC(C)C)Cc1c[nH]c2c1cccc2)Cc1ccc(cc1)O)NC(=O)C(Cc1c[nH]c2c1cccc2)NC(=O)C(NC(=O)C1CCC(=O)N1)Cc1nc[nH]c1
Isomeric SMILES OC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)CCCNC(=N)N)CC(C)C)Cc1c[nH]c2c1cccc2)Cc1ccc(cc1)O)NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H]1CCC(=O)N1)Cc1nc[nH]c1
InChI InChI=1S/C64H82N18O13/c1-34(2)23-46(56(88)75-45(13-7-21-69-64(66)67)63(95)82-22-8-14-52(82)62(94)72-31-53(65)85)76-58(90)48(25-36-28-70-42-11-5-3-9-40(36)42)78-57(89)47(24-35-15-17-39(84)18-16-35)77-61(93)51(32-83)81-59(91)49(26-37-29-71-43-12-6-4-10-41(37)43)79-60(92)50(27-38-30-68-33-73-38)80-55(87)44-19-20-54(86)74-44/h3-6,9-12,15-18,28-30,33-34,44-52,70-71,83-84H,7-8,13-14,19-27,31-32H2,1-2H3,(H2,65,85)(H,68,73)(H,72,94)(H,74,86)(H,75,88)(H,76,90)(H,77,93)(H,78,89)(H,79,92)(H,80,87)(H,81,91)(H4,66,67,69)/t44-,45-,46-,47-,48+,49-,50-,51-,52-/m0/s1
InChI Key VXKHXGOKWPXYNA-PGBVPBMZSA-N
No information available.
Summary of Clinical Use Click here for help
Extended-release formulations containing triptorelin pamoate are approved for the treatment of various indications including advanced stage prostate cancer, endometriosis, uterine fibroids and GnRH-dependent central precocious puberty (CPP), and are also used in in vitro fertilization programs. TriptodurTM is an extended-release formulation administered at 6 month intervals for CPP.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
Triptorelin is a peptide agonist analogue of gonadotropin-releasing hormone (GnRH). When given continuously triptorelin down-regulates GnRH receptor activity, thereby inhibiting the release of the gonadotrophins, LH and FSH. This results in a marked reduction of testicular (and ovarian) steroidogenesis.
External links Click here for help